In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.

Biogen Inc. Balance Sheet Statement - Assets

As of 31 Dec 2025, The total current assets of Biogen Inc. (NASDAQ:BIIB) was around $8,974,100,000 which consisted of $3,008,500,000 of Cash, $2,168,100,000 of Inventory and $1,867,000,000 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.

All amounts in USD

Cash
$3,008,500,000
Current assets
$8,974,100,000
Total assets
$29,439,500,000

The latest balance sheet of Biogen Inc. also showed $3,320,800,000 of Property Plant Equipment and $6,491,100,000 of Good will. Also there were $9,178,500,000 of Intangible assets and no Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $29,439,500,000.

Biogen Inc. Balance Sheet Statement - Liabilities

BIIB's latest annual results shows the balance sheet has $432,000,000 of Accounts Payable. Also there were $6,577,200,000 of Short/Long term debt, $6,286,800,000 of Long term debt, no Other Current liabilities and $3,349,400,000 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.

Account payable
$432,000,000
Current liabilities
$3,349,400,000
Total liabilities
$11,182,700,000

As per the 31 Dec 2025's annual report of Biogen Inc., the total liabilities were $11,182,700,000.

BIIB Balance Sheet Statement - Stock Holder Equity

Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.

The latest Balance sheet of Biogen Inc. showed the total stock holder equity was $18,256,800,000 which consisted of $100,000 of Common stocks, $20,552,700,000 of Retained earnings and no Other stock holder equity.

BIIB Balance Sheet Statement History

Following table shows the history of balance sheet for Biogen Inc. (BIIB).

31 Dec 2025 31 Dec 2024 31 Dec 2023 31 Dec 2022 31 Dec 2021
Cash 3,008,500,000 2,375,000,000 1,049,900,000 3,419,300,000 -
Net Receivables 1,867,000,000 1,868,800,000 2,100,000,000 2,136,400,000 -
Inventory 2,168,100,000 2,460,500,000 2,527,400,000 1,344,400,000 -
Total Current Assets 8,974,100,000 7,456,800,000 6,859,300,000 9,791,200,000 -
Property Plant Equipment 3,320,800,000 3,537,700,000 3,729,700,000 3,702,500,000 -
Good Will 6,491,100,000 6,478,900,000 6,219,200,000 5,749,000,000 -
Intangible Assets 9,178,500,000 9,691,200,000 8,363,000,000 1,850,100,000 -
Other Assets - - - - -
Deferred Long Term Asset Charges - - - - -
Total Assets 29,439,500,000 28,049,300,000 26,844,800,000 24,554,100,000 -
Accounts Payable 432,000,000 424,200,000 403,300,000 491,500,000 -
Short/Long Term Debt 6,577,200,000 6,630,300,000 7,338,200,000 6,614,000,000 -
Other Current Liabilities - - 838,400,000 746,900,000 10,800,000
Long Term Debt 6,286,800,000 4,547,200,000 6,788,200,000 6,281,000,000 -
Other Liabilities - - - - -
Total Current Liabilities 3,349,400,000 5,528,800,000 3,434,300,000 3,272,800,000 -
Total Liabilities 11,182,700,000 11,333,300,000 12,045,400,000 11,165,700,000 -
Common Stock 100,000 100,000 100,000 100,000 -
Retained Earnings 20,552,700,000 19,259,800,000 17,627,600,000 16,466,500,000 -
Treasury Stock 2,977,100,000 2,977,100,000 2,977,100,000 2,977,100,000 -
Other Stockholder Equity - - - - -
Total Stockholder Equity 18,256,800,000 16,716,000,000 14,799,400,000 13,397,900,000 -
Net Tangible Assets 2,587,200,000 545,900,000 217,200,000 5,798,800,000 -

Biogen Inc. (NASDAQ:BIIB) Balance Sheet Statement FAQ

1. How much Cash Biogen Inc. has on their balance sheet?

As of 31 Dec 2025, Biogen Inc. (NASDAQ:BIIB) has $3,008,500,000 of Cash.

2. What's the long term debt of Biogen Inc.?

As per the latest Balance sheet of Biogen Inc. (NASDAQ:BIIB), it has $6,286,800,000 of Long term debt.

3. How much share holder equity does Biogen Inc. has?

The Biogen Inc. (NASDAQ:BIIB)'s balance sheet shows that it has $18,256,800,000 of Total stock holder equity.